Ulcerative colitis and clinical course: Results of a 5-year population-based follow-up study (The IBSEN Study)

Inflammatory Bowel Diseases

Volumn 12, Issue 7, 2006, Pages 543-550

  Henriksen, Magne ^a,h   Jahnsen, Jørgen ^b   Lygren, Idar ^c   Sauar, Jostein ^d   Kjellevold, Øystein ^e   Schulz, Tom ^f   Vatn, Morten H ^g   Moum, Bjørn ^a  

^a Østfold Hospital   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d TELEMARK HOSPITAL   (Norway)

^e Blefjell sykehus HF   (Norway)

^f Aust Agder Central Hospital   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

^h Østfold Central Hospital Moss   (Norway)

Author keywords

Clinical course; Follow up; Prognosis; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; MESALAZINE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL EXAMINATION; COLITIS; COLON RESECTION; COLONOSCOPY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; PROSPECTIVE STUDY; RELAPSE; SYMPTOMATOLOGY; ULCERATIVE COLITIS;

EID: 33745521197     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000225339.91484.fc     Document Type: Article

References (30)

1. Ayres RC, Gillen CD, Walmsley RS, et al. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hepatol. 1996;8:555-558.
2. Hiwatashi N, Yamazaki H, Kimura M, et al. Clinical course and long-term prognosis of Japanese patients with ulcerative colitis. Gastroenterol Jpn. 1991;26:312-318.
3. Stonnington CM, Phillips SF, Zinsmeister AR, et al. Prognosis of chronic ulcerative colitis in a community. Gut. 1987;28:1261-1266.
4. Stewenius J, Adnerhill I, Ekelund GR, et al. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum. 1996;39:1019-1025.
5. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up study of 1116 patients. Dig Dis Sci. 1993;38:1137-1146.
6. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut. 1963;4:299-315.
7. Lanfranchi GA, Brignola C, Michelini M, et al. Clinical course of ulcerative colitis in Italy. Digestion. 1980;20:106-110.
8. Triantafillidis JK, Emmanouilidis A, Manousos ON, et al. Ulcerative colitis in Greece: clinicoepidemiological data, course, and prognostic factors in 413 consecutive patients. J Clin Gastroenterol. 1998;27:204-210.
9. Softley A, Clamp SE, Watkinson G, et al. The natural history of inflammatory bowel disease: has there been a change in the last 20 years. Scand J Gastroenterol. 1988;144:20-23.
10. Moum B, Ekbom A, Vatn MH, et al. Clinical course during the first year after diagnosis in ulcerative colitis and Crohn's disease. Scand J Gastroenterol. 1997;32:1005-1012.
11. Moum B, Vatn M, Ekbom A, et al. Incidence of inflammatory bowel disease in southeastern Norway. Evaluation of methods after one year of registration. Digestion. 1995;56:377-381.
12. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut. 1990;31:239-233.
13. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103:1444-1451.
14. Sinclair TS, Brunt PW, Mowat NA. Nonspesific proctocolitis in northeastern Scotland: a community study. Gastroenterology. 1983;85:1-11.
15. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50:485-489.
16. Moody GA, Jayanthi V, Probert CS, et al. Long-term therapy with sulfasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol. 1996;8:1179-1183.
17. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2000;14:145-153.
18. Ekbom A, Helmick C, Zack M, et al. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991;100:350-358.
19. Lennard-Jones JE, Shivananda S. Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe. Eur J Gastroenterol Hepatol. 1997;9:353-359.
20. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3-11.
21. Bresci G, Parisi G, Bertoni M, et al. Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up. Dig Liver Dis. 2002;34:419-423.
22. Powell-Tuck J, Ritchie JK, Lennard-Jones JE. The prognosis of idiopathic proctitis. Scand J Gastroenterol. 1977;12:727-732.
23. Ritchie JK, Powell-Tuck J, Lennard-Jones JE. Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet. 1978;1:1140-1143.
24. Bresci G, Parisi G, Gambardella L, et al. Evaluation of clinical patterns in ulcerative colitis: a long term follow-up. Int J Clin Pharmacol Res. 1997;17:17-22.
25. Langholz E, Munkholm P, Davidsen M. Changes in extent of ulcerative colitis. Scand J Gastroenterol. 1996;31:260-266.
26. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis: based on results from a regional patient group from the county of Copenhagen. Gut. 1985;26:158-163.
27. Witte J, Shivananda S, Lennard-Jones JE, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European collaborative study on inflammatory bowel disease (EC-IBD). Scand J Gastroenterol. 2000;35:1272-1277.
28. Isgar B, Harman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190-192.
29. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389-396.
30. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behaviour. Dig Dis Sci. 2004;49:469-474.